ClinicalTrials.Veeva

Menu

A Registry of Peripartum Cardiomyopathy in Turkey

E

Ege University

Status

Unknown

Conditions

Peripartum Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

NCT03364140
TKD-PPKM

Details and patient eligibility

About

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

Full description

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in centres in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

The objectives of the study are:

To define the clinical status and clinical characteristics of PPCM in Turkey

To define the outcome of PPCM (short and long term)

To define the demographical and possible etiological factors

To define prognostic factors

Enrollment

50 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient above 18 years of age
  • Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period
  • Ejection fraction less than 45% documented with echocardiography

Exclusion criteria

  • Patients with any other known cardiac pathology

Trial contacts and locations

1

Loading...

Central trial contact

Meral Kayikcioglu; Meral Kayikcioglu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems